References
- http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022041s008s009lbl.pdf. Accessed 10/15/12.
- Fortin JL, Giocanti JP, Ruttimann M, Kowalski JJ. Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Clin Toxicol (Phila) 2006; 44:37–44.
- Curry SC, Connor DA, Raschke RA. Effect of the cyanide antidote hydroxocobalamin on commonly ordered serum chemistry studies. Ann Emerg Med 1994; 24:65–67.
- Pamidi PV, DeAbreu M, Kim D, Mansouri S. Hydroxocobalamin and cyanocobalamin interference on co-oximetry based hemoglobin measurements. Clin Chim Acta 2009; 401:63–67. Epub 2008 Nov 18.
- Carlsson CJ, Hansen HE, Hilsted L, Malm J, Ødum L, Szecsi PB. An evaluation of the interference of hydroxycobalamin with chemistry and co-oximetry tests on nine commonly used instruments. Scand J Clin Lab Invest 2011; 71:378–386. Epub 2011 Apr 18.
- Sutter M, Tereshchenko N, Rafii R, Daubert GP. Hemodialysis complications of hydroxocobalamin: a case report. J Med Toxicol 2010; 6:165–167.
- Misra M. The basics of hemodialysis equipment. Hemodial Int 2005; 9:30–36.
- Valcarcel M. Principles of Analytical Chemistry. New York: Springer Heidelberg Germany; 2000; 11–184.
- Bruno TJ, Svoronos PDN. CRC Handbook of Fundamental Spectroscopic Correlation Charts. New York: CRC Press; 2005; 2–30.
- Abdelmalek J, Thornton S, Nizar J, Schneir A, Sanchez AP. Successful use of continuous renal replacement therapy after hydroxocobalamin administration. Dial Transplant 2011; 40:415–417.
- Fresenius Medical Care. Annual Report 2011. http://annualreport2011.fresenius.com/reports/fresenius/annual/2011/gb/English/105010/ fresenius-medical-care.html. Accessed 8/24/12.
- Gambro Healthcare. http://www.gambro.com/en/usa/About-Gambro/Gambro-in-brief/ Accessed 8/24/12.